Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mass Balance of [14C]Vapendavir in Healthy Males
NCT06834295Phase 2Completed
- Sponsor
- Altesa BioSciences
- Start
- Mar 2025
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Vapendavir in rhinovirus infection, enterovirus infection, sponsored by Altesa BioSciences. Started Mar 2025; status: completed.
02
Drugs
Vapendavir
03
Conditions
rhinovirus infectionenterovirus infection
Beyond the preview
Go deeper on NCT06834295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06834295.